Skip to main content

Currently Skimming:

Forum Themes and Priorities
Pages 18-21

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 18...
... There is increasing recognition of the need for new models and methodologies to advance drug discovery, development, and translational science. The Forum serves as a hub and a catalyst for nurturing new ideas, collaborations, and partnerships and offers a neutral space for stakeholders to help chart a course through the turbulent forces of disruptive innovation and advance critical policy discussions on biopharmaceutical R&D nationally and globally.
From page 19...
... Clinical Trials and Medical Product Development Clinical research provides a critical link between the laboratory bench and patients' bedside when it comes to developing new therapeutics and advancing understanding of health maintenance and prevention and disease progression. However, the clinical research enterprise faces continued and mounting pressures, strained from all sides by rising costs, an evolving regulatory and economic landscape, increasing clinical trial complexity, difficulties in the recruitment and retention of research participants, and a clinical research workforce that is under tremendous stress.
From page 20...
... these fields are difficult to pursue, training may be lacking, and career opportunities may be limited. The Forum has considered workforce needs as foundational for the advancement of drug discovery, development, and translation and has focused substantial attention on these issues and fostered the development of strategies to improve the discipline of innovative regulatory science through the development of a robust workforce.
From page 21...
... . MEMBERS Facilitate visibility and continuous discussion on important issues Foster collaboration on topics where there is synergy among potential partners Explore innovative and transformative approaches for resolving problem areas Educate and elevate understanding of issues Acade Exp Patient- & Disease Clarify and expand areas of Focused Organizations agreement Biopharma Com Foundations & Nonprofit Funders Set the stage for future Federal ü ü policy action Consortia & Regulator ü Associations 21 Topics addressed by the Forum span a broad range The Forum has approximately 30-35 me


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.